NAMS
NewAmsterdam Pharma Co N.V.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 6/5/2026 | View on SEC |
| SCHEDULE 13G/A | 6/4/2026 | View on SEC |
| 8-K | 6/3/2026 | View on SEC |
| 4 | 5/27/2026 | View on SEC |
| 144 | 5/26/2026 | View on SEC |
| SCHEDULE 13D/A | 5/14/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 10-Q | 5/7/2026 | View on SEC |
| SCHEDULE 13G/A | 5/6/2026 | View on SEC |
| ARS | 5/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NAMS |
| Company Name | NewAmsterdam Pharma Co N.V. |
| CIK | 1936258 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | P7 |
| Phone | 35 206 2971 |